Intro
Biopharma Cold Chain 2011 Sourcebook
The Biopharma Cold Chain 2011 Sourcebook is a comprehensive business guide to the world’s supply chain for temperature-sensitive drugs and biologics. The updated 2011 edition provides an assessment and forecast of cold-chain logistics spending worldwide, and a detailed and up-to-date analysis of regulatory, market, technological and business developments that are expanding the demand for temperature-assured storage and transportation and improving the supply chain’s ability to deliver that assurance.
By Mark Lipowicz and Nicholas Basta, Pharmaceutical Commerce
and Editorial Adviser: Rafik Bishara, PhD, Pharmaceutical Cold Chain Interest Group
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
